Pharmacological HIF-PH Inhibition Suppresses Myoblast Differentiation Through Continued HIF-1α Stabilization
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115410 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yuya Miki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Cell Differentiation, Myoblasts, Hypoxia-Inducible Factor-Proline Dioxygenases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Osaka Medical Research Foundation for Intractable Diseases, Osaka Medical Research Foundation for Intractable Diseases.
Abstract (Originalsprache)
Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors continually stabilize hypoxia-inducible factor-1α (HIF-1α). These inhibitors are effective in the clinical treatment of renal anemia. However, the effects of continued HIF-1α stabilization on skeletal muscle differentiation remain unclear. This study aimed to investigate the effects of continued HIF-1α stabilization on skeletal muscle differentiation using a HIF-PH inhibitor in both in vitro and in vivo models. We cultured mouse C2C12 myoblasts to differentiate into myotubes with or without FG-4592, a HIF-PH inhibitor. Additionally, we treated nine-week-old male C57BL/6 mice with either FG-4592 or vehicle via intraperitoneal injections three times a week for four weeks. In vitro, FG-4592 treatment stabilized HIF-1α continually. Morphological analysis revealed that 72 h FG-4592 treatment suppressed differentiation of C2C12 myoblasts into myotubes. This treatment decreased the gene and protein expression of MyoD and myogenin, reduced the protein expression of myosin heavy chain (MHC), and increased the gene and protein expression of myostatin. HIF-1α knockdown mitigated the decrease in MHC protein expression induced by FG-4592. In vivo, FG-4592 treatment increased HIF-1α protein expression and decreased MyoD, myogenin, and MHC protein expression in gastrocnemius muscle. These findings suggest that pharmacological HIF-PH inhibition suppresses myoblast differentiation through continued HIF-1α stabilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
- Division of Internal Medicine, Inoue Hospital, Osaka 564-0053, Japan.
- Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
- Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
- Department of Nephrology, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
ORCID-Profile: Akinobu Ochi, Yuki Nagata, Katsuhito Mori, Tetsuo Shoji, Tomoaki Morioka
Förderung
- The Osaka Medical Research Foundation for Intractable Diseases
- Osaka Medical Research Foundation for Intractable Diseases
Zitieren
APA
Miki, Y., Ochi, A., Uedono, H., Kakutani, Y., Ichii, M., Nagata, Y., Mori, K., Imanishi, Y., Shoji, T., Morioka, T., & Emoto, M. (2025). Pharmacological HIF-PH Inhibition Suppresses Myoblast Differentiation Through Continued HIF-1α Stabilization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115410
Vancouver
Miki Y, Ochi A, Uedono H, Kakutani Y, Ichii M, Nagata Y, et al. Pharmacological HIF-PH Inhibition Suppresses Myoblast Differentiation Through Continued HIF-1α Stabilization. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115410
BibTeX
@article{Miki2025,
author = {Miki, Yuya and Ochi, Akinobu and Uedono, Hideki and Kakutani, Yoshinori and Ichii, Mitsuru and Nagata, Yuki and Mori, Katsuhito and Imanishi, Yasuo and Shoji, Tetsuo and Morioka, Tomoaki and Emoto, Masanori},
title = {Pharmacological HIF-PH Inhibition Suppresses Myoblast Differentiation Through Continued HIF-1α Stabilization},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115410}
}
EUVIMED